Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| 1 |
Stellantis
STLA
|
+$292M |
| 2 |
Constellation Brands
STZ
|
+$288M |
| 3 |
VMW
VMware, Inc
VMW
|
+$273M |
| 4 |
SPDR S&P Biotech ETF
XBI
|
+$261M |
| 5 |
NiSource
NI
|
+$240M |
Top Sells
| 1 |
Microsoft
MSFT
|
+$2.05B |
| 2 |
Apple
AAPL
|
+$1.81B |
| 3 |
UnitedHealth
UNH
|
+$1.01B |
| 4 |
Exxon Mobil
XOM
|
+$862M |
| 5 |
Tesla
TSLA
|
+$834M |
Sector Composition
| 1 | Technology | 27.58% |
| 2 | Consumer Discretionary | 11.38% |
| 3 | Healthcare | 10.81% |
| 4 | Financials | 10.71% |
| 5 | Communication Services | 6.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2501
E.W. Scripps
SSP
$248M
| $543K | ﹤0.01% |
57,664
+14,432
| +33% | +$136K |
|
2502
Steelcase
SCS
$1.94B
| $542K | ﹤0.01% |
64,314
+12,401
| +24% | +$105K |
|
|
API
2503
Agora
API
$347M
| $541K | ﹤0.01% |
149,535
+40,036
| +37% | +$145K |
|
2504
FIGS
FIGS
$1.2B
| $539K | ﹤0.01% |
87,208
-214,445
| -71% | -$1.33M |
|
2505
Gold Fields
GFI
$34.8B
| $539K | ﹤0.01% |
40,443
+34,443
| +574% | +$459K |
|
2506
Haverty Furniture Companies
HVT
$377M
| $539K | ﹤0.01% |
16,913
+2,034
| +14% | +$64.8K |
|
2507
TTEC Holdings
TTEC
$173M
| $539K | ﹤0.01% |
14,472
+306
| +2% | +$11.4K |
|
2508
Caribou Biosciences
CRBU
$170M
| $538K | ﹤0.01% |
101,192
-18,899
| -16% | -$100K |
|
|
EH
2509
EHang Holdings
EH
$1.22B
| $537K | ﹤0.01% |
49,134
| – | – |
|
2510
Donnelley Financial Solutions
DFIN
$1.48B
| $536K | ﹤0.01% |
13,113
+924
| +8% | +$37.8K |
|
2511
Columbia Financial
CLBK
$1.61B
| $535K | ﹤0.01% |
29,287
+20,144
| +220% | +$368K |
|
|
JKS
2512
JinkoSolar
JKS
$1.36B
| $532K | ﹤0.01% |
10,426
-177,202
| -94% | -$9.04M |
|
|
MITA
2513
DELISTED
Coliseum Acquisition Corp. Class A Ordinary Share
MITA
| $532K | ﹤0.01% |
52,033
| – | – |
|
2514
Cytek Biosciences
CTKB
$504M
| $531K | ﹤0.01% |
57,789
+27,130
| +88% | +$249K |
|
|
AMED
2515
DELISTED
Amedisys
AMED
| $530K | ﹤0.01% |
7,198
-6,401
| -47% | -$471K |
|
2516
Integral Ad Science
IAS
$1.39B
| $530K | ﹤0.01% |
37,153
-946
| -2% | -$13.5K |
|
|
PETWW
2517
DELISTED
Wag! Group Co Warrant
PETWW
| $529K | ﹤0.01% |
239,500
| – | – |
|
2518
CVRx
CVRX
$180M
| $528K | ﹤0.01% |
+56,679
| New | +$528K |
|
|
INVX
2519
Innovex International, Inc.
INVX
$1.14B
| $527K | ﹤0.01% |
18,391
+1,110
| +6% | +$31.8K |
|
2520
Actinium Pharmaceuticals
ATNM
$50.5M
| $526K | ﹤0.01% |
+55,662
| New | +$526K |
|
2521
AZZ Inc
AZZ
$3.46B
| $526K | ﹤0.01% |
12,743
+804
| +7% | +$33.2K |
|
|
RC
2522
Ready Capital
RC
$695M
| $525K | ﹤0.01% |
51,604
-3,573
| -6% | -$36.4K |
|
|
EVBN
2523
DELISTED
Evans Bancorp Inc
EVBN
| $525K | ﹤0.01% |
15,639
-581
| -4% | -$19.5K |
|
|
CMRC
2524
Commerce.com, Inc. Series 1 Common Stock
CMRC
$380M
| $524K | ﹤0.01% |
58,725
-204,969
| -78% | -$1.83M |
|
2525
Abeona Therapeutics
ABEO
$293M
| $523K | ﹤0.01% |
185,638
| – | – |
|